Follow the latest research regarding osteoarthritis treatment options.

Pain Relievers: Handle with Care

An FDA advisory committee met recently to discuss the problem of serious liver damage caused by overuse of a common medication: acetaminophen. This popular pain reliever is found in about 600 products, including over-the-counter pain relievers (for example, Tylenol®, Excedrin®), prescription pain medications (for example, Vicodin®, Percocet®), cough-and-cold products and sleep aids.

This is important news for people with osteoarthritis of the knee since over-the-counter acetaminophen is often used to relieve pain. For those with more severe pain, doctors sometimes prescribe medications that combine acetaminophen with a stronger pain reliever, such as codeine or hydrocodone.

Acetaminophen is generally safe at recommended doses, but taking too much can cause serious — even life-threatening — problems. The issue is that it’s easy to mistakenly take more acetaminophen than you mean to. Let’s say you’re someone with osteoarthritis who’s fighting a cold. In addition to taking Tylenol for your knee pain, you take a cough-and-cold product for the cold symptoms. You might wind up getting more acetaminophen than you bargained for. 

Too much of a good thing

The liver problems caused by too much acetaminophen range from abnormal results on liver function tests to acute liver failure — a medical emergency in which the liver rapidly loses its ability to work properly.

The recommended total daily dose for adults is 4,000 mg a day, which is equal to 8 pills of most over-the-counter acetaminophen. Taking a much larger dose can lead to liver damage. But in some people, taking just a little more than the recommended amount can injure the liver, too. Those who drink alcohol or who already have liver disease may be especially vulnerable. 

Echoes of problems past

It’s not the first time the dangers of pain relievers that are common for osteoarthritis of the knee have made headlines. In 2005, the FDA strengthened warnings about potential side effects of NSAIDs (nonsteroidal anti-inflammatory drugs), a group of medications that include over-the-counter and prescription products like ibuprofen, Celebrex® and aspirin. It was found that regular use of NSAIDs has the potential to cause stomach bleeding. In addition, long-term use of all NSAIDs except aspirin may increase the risk for heart attack or stroke.

Make safety your priority

The take-home message: Even the most familiar pain relievers need to be handled with care. All pain relievers are serious, even non-prescription ones. The steps below can help you avoid unintended consequences:

  • Read the package carefully: don’t take more than the recommended dose and don’t take it more often than directed.
  • Know what you’re taking: check a medicine’s label to see if it contains acetaminophen. On a prescription medication, acetaminophen is sometimes listed as “APAP.”
  • Talk with your doctor: make sure your doctor knows all the medications you’re taking, even over-the-counter. Check with your doctor or pharmacist before taking a new medication.

PLEASE NOTE: Tylenol is a registered trademark of The Tylenol Company. Excedrin is a registered trademark of Novartis Consumer Health, Inc. Vicodin is a registered trademark of Knoll Pharmaceutical Company. Percocet is a registered trademark of Endo Pharmaceuticals Inc. Celebrex is a registered trademark of G.D. Searle, LLC.

The studies and their findings that are presented in this article are for informational purposes only and are not meant to take the place of the advice of your doctor. By providing you with this information, Genzyme Corporation is not endorsing its content. You should consult with your doctor before starting any new health regimen.

References

“Acetaminophen and Liver Injury: Q&A for Consumers.” Food and Drug Administration. Accessed August 9, 2009.

“Health Bulletin: Use Caution With Pain Relievers.” Food and Drug Administration. Accessed August 9, 2009.

“Acetaminophen Overdose and Liver Injury: Background and Options for Reducing Injury.” Food and Drug Administration. Accessed August 9, 2009. (p. 1 What Is Acetaminophen and What Is It Used For?)

“FDA Announces Series of Changes to the Class of Marketed Non-steroidal Anti-inflammatory Drugs (NSAIDs).” Food and Drug Administration. Accessed August 9, 2009.

“The Benefits and Risks of Pain Relievers: Q&A on NSAIDs With Sharon Hertz, M.D.” Food and Drug Administration. Accessed August 9, 2009.

Find a Synvisc-One Doctor

Sign up for emails from
Synvisc-One



Knee Exercise Videos

Watch these simple exercises, designed specifically for knees with osteoarthritis, and add them to your daily routine.

Watch knee exercise videos

Indication

Synvisc-One® (hylan G-F 20) and SYNVISC® (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

Important Safety Information

Before trying Synvisc-One or SYNVISC, tell your doctor if you are allergic to products from birds — such as feathers, eggs or poultry — or if your leg is swollen or infected. Synvisc-One and SYNVISC are only for injection into the knee, performed by a doctor or other qualified health care professional. Synvisc-One and SYNVISC have not been tested to show pain relief in joints other than the knee. Talk to your doctor before resuming strenuous weight-bearing activities after treatment. Synvisc-One and SYNVISC have not been tested in children, pregnant women or women who are nursing. You should tell your doctor if you think you are pregnant or if you are nursing a child. The side effects most commonly seen when Synvisc-One or SYNVISC is injected into the knee were pain, swelling and/or fluid buildup in or around the knee. Cases where the swelling is extensive or painful should be discussed with your doctor. Allergic reactions such as rash and hives have been reported rarely.

View the Complete Prescribing Information for Synvisc-One (PDF)
View the Complete Prescribing Information for SYNVISC (PDF)